News
Latest News
2026 Must-Know scientific skincare for sensitive skin! Dermatologist analyzes “PLT” Combination Therapy to help sensitive skin regain its radiance
Redness, itching, dryness, peeling, or constant "breakouts"? Sensitivity is not just a skin condition; it is a long-term constitution that requires precise management. As regenerative medicine continues to advance, Dr. Cheng Hui-wen, an attending dermatologist at Anser Medical Clinic, shares that "PLT"—with its highly purified and quantified growth factor formula—has officially become the most critical "skin-stabilizing solution" for sensitive skin treatments. It can activate the skin's self-healing power, repair the barrier, reduce chronic inflammation, and enhance the skin base's tolerance. Most importantly, it has low rejection rates, making it safe
Optimizing Biofoundry Technology: Spirit Scientific Explores New Applications in Regenerative Medicine
Regenerative medicine has become a rapidly growing global industry due to its properties of promoting repair and delaying degeneration. The market size is estimated to rise from US$35.5 billion in 2024 to US$90 billion by 2030. Founded in 2015, Spirit Scientific Co., Ltd., led by Founder and Chairman Steven D Lin,MD , centers its core on "Biofoundry™" engineering. By combining pharmaceutical-grade specifications to develop BMLT® , the company has extended from high-concentration platelet growth factor extraction to diverse material applications, driving the standardization and normalization of regenerative medicine. Precision Preparation
Spirit Scientific passes Japan PMDA audit for cell processing facilities, showcasing biofoundry™ strength
Spirit Scientific (7790) Becomes first company to receive PMDA certification for Platelet Lyophilization Processing Facilities On December 1, emerging biotech company Spirit Scientific (7790), listed on Taiwan's over-the-counter market, announced a major regulatory milestone. On November 20, the company received notification from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) under the Ministry of Health, Labour and Welfare (MHLW) confirming the successful completion of the overseas specified cell processing facility inspection. This achievement grants Spirit Scientific the Specified Cell Processed Products Manufacturing Certification from the Japanese MHLW, making it the first Taiwanese
Spirit Scientific BioTech Wins Ministry of Economic Affairs'”Startup Award,” Innovative Operating Strategy Recognized
Nov 19, 2025, The 24th "Startup Award" ceremony, hosted by the Ministry of Economic Affairs (MOEA), was grandly held yesterday at the NTUH International Convention Center. Spirit Scientific BioTech (7790), which focuses on precision regenerative medicine, was honored with the "Startup Award" in the Technology Industry category, demonstrating recognition for its technical innovation and outstanding operating performance.Spirit Scientific BioTech stated that it holds the core technology of Biological Material Lyophilization Technology (BMLT ®) and has developed an innovative service model: the Biofoundry™ Diamond-Grade Lyophilization Preparation Service. This model provides standardized and
Spirit Scientific gains recognition with double bronze for 2 patents at Innotech Expo, highlighting solutions for PRP limitations at Taiwanese Orthopaedic Association
Spirit Scientific Wins Awards at 2025 Taiwan Innotech Expo, Highlighting Precision Regenerative Medicine Innovations Spirit Scientific (7790), a company focusing on precision regenerative medicine, recently showcased two innovative patented technologies at the 2025 Taiwan Innotech Expo (TIE): "A Growth Factor-Rich Dry Powder for Use in Alleviating Inflammation or Injury" and "A Platelet-Containing Composition and Method for Preparing the Same." Both technologies earned the company Bronze Medals in the invention competition. Spirit Scientific stated that both patents are based on the company's core Biological Material Lyophilization Technology (BMLT). This achievement demonstrates
Spirit Scientific Biotech: Innovating regenerative medicine by turning biomaterials into pharmaceuticals
Spirit Scientific Biotech is participating in the BIO Asia-Taiwan exhibition for the first time. The well-known media outlet conducted a interview video with us. Steven D. Lin, co-founder and chairman of Spirit Scientific Biotech, made his first appearance at BIO Asia-Taiwan, sharing the company's innovative plans in the field of regenerative medicine. Spirit Scientific Biotech focuses on the pharmaceutical and standardization of biomaterials. Their core technology, BMLT, can significantly improve the stability and shelf life of biomaterials. Their first product, Platelet Lyphoilized Treatment (PLT), is currently the safest
Vice President acknowledge Golden Ship Award winners as Taiwan’s pride, showcase Taiwan’s strength to the world.
Vice President Meets with the Winners of the 7th Brand Golden Ship Award. Vice President Hsiao Bi-khim today (the 5th) met with the award-winning enterprises of the 7th Brand Golden Ship Award. She affirmed that the award-winning companies are the pride of Taiwan and emphasized that the government will support all sectors, serving as a strong backing for the industry. She expressed hope for a joint effort to showcase Taiwan's strength to the world. In her remarks, the Vice President stated that it was a great honor to receive the
Spirit Scientific biotech featured in famous media, Global Bio & Investment, Vol. 128
Spirit Scientific biotech featured in famous media, Global Bio & Investment, Vol. 128 Source: https://news.gbimonthly.com/tw/magazine/article_show.php?num=78723
Spirit Scientific biotech debuts at BIO Asia with key lyophilization technology, enabling precise PRP medicine
Spirit Scientific biotech, leader in regenerative medicine, made its debut at BIO Asia-Taiwan 2025. The company showcased its core BMLT®, which transforms biomaterials into stable, quantifiable, and lyophilized forms. This technology's key application is in enhancing traditional PRP (platelet-rich plasma) therapy. By preparing a precise, consistent Platelet Lyophilized Treatment(PLT) product, Spirit Scientific biotech eliminates the variability of standard PRP injections. With over 36,000 cases and partnerships with more than 1,300 medical institutions, the company is now seeking new collaborations to expand its technology's applications. Spirit Scientific biotech has also established
Platelet Lyophilized Treatment (PLT) offers a new, regenerative approach to male sexual health
A growing number of men are seeking solutions for sexual health issues, which can often be an early warning sign of other health problems like diabetes or heart disease. As a result, regenerative medicine is offering new, less invasive treatment options. Dr. Ku Fang-yu, a urologist, highlights a key innovation: Platelet Lyophilized Treatment (PLT). This therapy involves using a highly concentrated, standardized, and lyophilized product derived from a patient's own blood. Unlike traditional PRP (platelet-rich plasma), PLT is consistently dosed and ready-to-use, eliminating the need for a blood draw at
Spirit Scientific biotech’s PLT preparation service grabs attention at tokyo regenerative medicine expo
Spirit Scientific biotech Expands Globally, Shines at Tokyo and BIO Asia Expos Spirit Scientific biotech, a company focused on standardized regenerative medicine, showcased its innovative BMLT® at 2 major expos: the Regenerative Medicine Expo TOKYO and the upcoming BIO Asia-Taiwan. The company's core technology allows it to transform biological materials into stable, precise, and easy-to-use lyophilized products like Platelet Lyophilized Treatment(PLT). This offers a major advantage over traditional therapies like PRP, which can be inconsistent. With over 36,000 cases in Taiwan and a newly opened lab in Japan, Spirit Scientific
A New Era in Skincare: How PLT helps restore skin’s radiance
PLT, a new standard for skincare and rejuvenation A new regenerative medicine treatment, Platelet Lyophilized Treatment (PLT), is changing the landscape of professional skincare. Unlike traditional PRP (platelet-rich plasma), PLT is a standardized, lyophilized product derived from a patient's own blood (Autologous). According to dermatologist Dr. Lin Yue-feng, this innovative technology provides consistent, quantifiable doses of growth factors. When applied to the skin, these powerful proteins stimulate collagen and elastin production, which can help improve skin texture, reduce fine lines, and restore a natural glow. Dr. Lin stresses that while
